Serial passage of Pseudomonas aeruginosa ATCC 27853 or Escherichia coli ATCC 25922 on agar with subinhibitory concentrations of norfloxacin rapidly produced isolates with minimal inhibitory concentrations (MICs) of norfloxacin up to 512-fold higher than that for the original strain. Although MICs of seven unrelated antibiotics were unchanged, increasing MICs occurred in parallel with norfloxacin, cinoxacin, and nalidixic acid regardless of which of these three organic acids was used to select for increased resistance. P. aeruginosa with a norfloxacin MIC of greater than 256 F.g/ml could be selected; however, E. coli with MICs greater than the clinically achievable level of 16 Fg/ml could not be produced.
Rapid selection or induction of resistance in gram-negative bacilli by passage on subinhibitory concentrations of nalidixic acid and cinoxacin is a well-described property of these organicacid antibiotics (3) . A recent report on norfloxacin, a very active, newly synthesized, organic-acid antibiotic, found that resistant clones of gram-negative bacilli did not develop within the zone of inhibition of a norfloxacin disk or in populations of organisms growing in broth with subinhibitory concentrations of norfloxacin (5 (6) . Although limited, our data suggest that investigators should be alert to the potential for emergence of clinically important resistance to norfloxacin in P. aeruginosa during clinical trials of this antibiotic.
